AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: life sciences AIClear filter
industryIQVIA

Therapeutic Areas Driving Clinical Trial Growth Show Where AI Will Face the Next Bottlenecks

IQVIA's look at therapeutic areas driving clinical trial growth is a reminder that AI in drug development will not spread evenly. The biggest opportunities may lie in the areas with the most data, complexity, and operational strain.

clinical trialsIQVIAdrug developmenttrial operations
industry

ByteDance’s Anew Labs Keeps Turning AI-Designed Drugs Into a Global Showcase

ByteDance’s Anew Labs is showcasing AI-designed drug candidates at global conferences in 2026, reinforcing the company’s ambition in life sciences. The strategy appears designed to convert technical credibility into international visibility.

IndexBox
ByteDanceAnew Labsdrug candidates
technology

OpenAI’s GPT-Rosalind Signals a New Phase in Life Sciences AI

OpenAI’s launch of GPT-Rosalind adds another heavyweight to the crowded race to build AI for drug discovery and biological research. The move underscores how foundation-model makers are now targeting one of the most valuable and technically demanding domains in science.

Lab Manager
OpenAIdrug discoveryfoundation models
technology

OpenAI’s GPT-Rosalind Brings Foundation Models Deeper Into Drug Discovery

OpenAI’s launch of GPT-Rosalind signals that foundation models are moving beyond generic biomedical assistance into purpose-built drug discovery tooling. The release intensifies competition among Big Tech, startups, and pharma over who will control the AI infrastructure behind future medicines.

qz.com
OpenAIfoundation modelsdrug discovery
industry

Big Tech’s Drug Discovery Push Is Turning AI Into a Life Sciences Platform War

Axios reports that Big Tech is circling drug discovery, reinforcing the idea that life sciences is becoming a strategic battleground for AI platforms. As major technology companies move closer to pharma, the competition is shifting from standalone tools to end-to-end ecosystems that can own the scientific workflow.

Axios
Big Techdrug discoverylife sciences AI

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.